M&A

Novo bags €430M Staten buyout option to boost cardiovascular disease pipeline
Fierce Biotech
Mon, 12/17/18 - 09:12 am
Novo Nordisk
Staten Biotechnology
M&A
Taisho Nears $1.6 Billion Deal for Bristol-Myers Unit
Bloomberg
Mon, 12/17/18 - 12:20 am
Taisho
Bristol-Myers Squibb
OTC
Upsa
M&A
Anatomy of a long-delayed biotech buyout: With its stock price beaten down, abandoned by potential bidders, Tesaro wound up in GSK’s eager arms
Endpoints
Sat, 12/15/18 - 11:44 pm
M&A
Tesaro
Zejula
GSK
Merck to Acquire Animal Tracking and Monitoring Company
CP Wire
Fri, 12/14/18 - 12:50 pm
Merck Animal Health
Merck
animal health
M&A
Antelliq
Astellas gains three cancer drugs with $405m Potenza buy
Pharmaforum
Fri, 12/14/18 - 12:47 pm
Astellas
Potenza Therapeutics
M&A
cancer immunotherapy
To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health
Xconomy
Wed, 12/12/18 - 09:51 am
Synergy Pharmaceuticals
bankruptcy
Bausch Health
M&A
Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger
Fierce Pharma
Mon, 12/10/18 - 07:02 pm
Akorn
Fresenius
M&A
Are Medtech Companies Still Interested in M&A?
Medical Devices and Diagnostics Industry
Mon, 12/10/18 - 11:51 am
devices
M&A
5 Top Drug/Biotech Merger & Acquisition Targets for 2019
Yahoo/Zacks.com
Mon, 12/10/18 - 09:50 am
M&A
Biomarin
Vertex Pharmaceuticals
Incyte
Alnylam
Alexion
Could These Be the Next 2 Biotech Buyouts?
Motley Fool
Sun, 12/9/18 - 03:41 pm
biotech
M&A
Agios Pharmaceuticals
Clovis Oncology
Millendo, OvaScience merge, raise $50M
BioCentury
Sat, 12/8/18 - 12:20 pm
Millendo Therapeutics
OvaScience
M&A
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
Fierce Pharma
Thu, 12/6/18 - 12:59 pm
Akorn
Fresenius
M&A
Mereo BioPharma, OncoMed agree to merge
Pharmaceutical Business Review
Thu, 12/6/18 - 09:57 am
M&A
Mereo BioPharma
OncoMed
A last-ditch effort to derail Takeda’s $62B Shire buyout goes down in flames
Endpoints
Wed, 12/5/18 - 09:46 am
Takeda
Shire
M&A
Should You Be Worried About the Return of Big Pharma Deals?
Motley Fool
Tue, 12/4/18 - 11:27 am
GSK
Tesaro
M&A
Big Pharma
JNJ
Argenx
GSK Pays $5.1B For Tesaro, Setting Up “PARP” Battle With Rival AstraZeneca
Xconomy
Mon, 12/3/18 - 10:11 am
GSK
M&A
Tesaro
PARP inhibitors
Zejula
AstraZeneca
Crown Laboratories buys select OTC consumer healthcare brands from GSK
Pharmaceutical Business Review
Mon, 12/3/18 - 10:10 am
Crown Laboratories
GSK
OTC
M&A
Judge threatened to delay or even spike $70m CVS-Aetna merger
Mass Device
Mon, 12/3/18 - 10:08 am
Aetna
CVS Health
M&A
Takeda Acquisition Of Shire May Bode Well For R&D Staff
Forbes
Mon, 12/3/18 - 10:05 am
Shire
Takeda
R&D
M&A
Takeda ready to dismiss assets for a total $10bn
GoinPharma
Sun, 12/2/18 - 12:35 pm
Takeda
Shire
M&A

Pages